TCT 217: Two-year Outcomes of Valve-in-Valve Using New Generation Transcatheter Devices Compared with Redo-SAVR

Presenter: Takashi Nagasaka

REGISTER for free or LOG IN to view this content

TCT 217: Two-year Outcomes of Valve-in-Valve Using New Generation Transcatheter Devices Compared with Redo-SAVR

We Recommend